Status:

RECRUITING

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Lead Sponsor:

Seattle Children's Hospital

Collaborating Sponsors:

Children's Hospital of Philadelphia

Dalhousie University

Conditions:

Crohn Disease

Eligibility:

All Genders

8-21 years

Phase:

NA

Brief Summary

This study will compare the tolerability and efficacy of conventional formula Exclusive Enteral Nutrition (EEN) and whole-food blended smoothie EEN by enrolling a total of 60 participants with newly d...

Eligibility Criteria

Inclusion

  • Age 8 -21 years old.
  • Diagnosis of Crohn's disease within 24 months
  • Elevation in objective inflammatory markers at enrollment: C-reactive protein (CRP), ESR, or fecal calprotectin
  • Active Crohn's disease, as defined by Pediatric Crohn's Disease Activity Index (PCDAI) ≥10.
  • Participant capable of giving informed consent, or if a minor the parent/guardian is capable of giving informed consent.

Exclusion

  • History of surgery for Crohn's disease.
  • Perianal disease as part of Crohn's disease phenotype.
  • Recent use of:
  • corticosteroids (within 4 weeks),
  • dose adjustment of immunomodulator (within 8 week)
  • azathioprine 4 weeks prior to study final visit (week 8)
  • start or adjust methotrexate 3 weeks prior to final study visit.
  • Prior use of biological medication
  • Prior treatment with EEN or other dietary therapy for Crohn's disease.
  • Prior treatment with antibiotics for Crohn's disease.
  • Known allergies to any of the food components in the smoothie.
  • Admission to hospital due to severity of Crohn's disease and associated symptoms.
  • Unwillingness to provide informed consent.

Key Trial Info

Start Date :

March 11 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 10 2030

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06216899

Start Date

March 11 2024

End Date

January 10 2030

Last Update

June 12 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19146

2

Seattle Children's Hospital

Seattle, Washington, United States, 98105

3

Izaak Walton Killam Health Centre

Halifax, Nova Scotia, Canada, B3J 0C3

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial | DecenTrialz